Bristol John W & Co. Inc. NY cut its position in shares of Monsanto Co. (NYSE:MON) by 52.4% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 283,649 shares of the company’s stock after selling 312,539 shares during the period. Bristol John W & Co. Inc. NY owned 0.06% of Monsanto worth $28,989,000 at the end of the most recent reporting period.

Several other hedge funds have also made changes to their positions in MON. Candriam Luxembourg S.C.A. acquired a new stake in shares of Monsanto during the second quarter worth $12,767,000. Nisa Investment Advisors LLC raised its stake in shares of Monsanto by 3.2% in the second quarter. Nisa Investment Advisors LLC now owns 189,692 shares of the company’s stock worth $19,616,000 after buying an additional 5,890 shares during the period. Shell Asset Management Co. raised its stake in shares of Monsanto by 7.7% in the second quarter. Shell Asset Management Co. now owns 131,594 shares of the company’s stock worth $13,608,000 after buying an additional 9,459 shares during the period. Mondrian Investment Partners LTD raised its stake in shares of Monsanto by 22.1% in the second quarter. Mondrian Investment Partners LTD now owns 785,779 shares of the company’s stock worth $81,257,000 after buying an additional 142,262 shares during the period. Finally, Carmignac Gestion acquired a new stake in shares of Monsanto during the second quarter worth $197,555,000. Institutional investors own 78.26% of the company’s stock.

Institutional Ownership by Quarter for Monsanto (NYSE:MON)

Shares of Monsanto Co. (NYSE:MON) traded up 0.11% on Monday, hitting $101.32. The stock had a trading volume of 1,458,273 shares. The company has a market capitalization of $44.38 billion, a price-to-earnings ratio of 33.91 and a beta of 1.01. The company has a 50-day moving average of $101.11 and a 200 day moving average of $103.79. Monsanto Co. has a 52 week low of $83.73 and a 52 week high of $114.26.

Monsanto (NYSE:MON) last announced its quarterly earnings results on Wednesday, October 5th. The company reported $0.07 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.02) by $0.09. The business had revenue of $2.56 billion for the quarter, compared to analyst estimates of $2.38 billion. Monsanto had a return on equity of 46.07% and a net margin of 9.89%. The company’s quarterly revenue was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the company earned ($0.19) earnings per share. On average, equities research analysts predict that Monsanto Co. will post $4.73 EPS for the current year.

Several research firms recently issued reports on MON. TheStreet cut Monsanto from a “buy” rating to a “hold” rating in a report on Monday, September 12th. Citigroup Inc. raised their price target on Monsanto from $112.00 to $116.00 and gave the company a “neutral” rating in a report on Friday, August 19th. Zacks Investment Research cut Monsanto from a “hold” rating to a “strong sell” rating in a report on Friday, October 7th. JPMorgan Chase & Co. set a $128.00 price target on Monsanto and gave the company a “buy” rating in a report on Thursday, October 6th. Finally, Monness Crespi & Hardt decreased their price target on Monsanto from $130.00 to $128.00 and set a “buy” rating on the stock in a report on Monday, October 3rd. Three equities research analysts have rated the stock with a sell rating, eight have given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company. Monsanto has a consensus rating of “Buy” and an average price target of $114.65.

In other news, Director Charles S. Mcmillan purchased 3,500 shares of the business’s stock in a transaction on Monday, October 10th. The shares were acquired at an average price of $103.23 per share, for a total transaction of $361,305.00. Following the completion of the acquisition, the director now owns 64,009 shares in the company, valued at $6,607,649.07. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Steven Mizell sold 310 shares of the stock in a transaction that occurred on Monday, October 10th. The stock was sold at an average price of $103.09, for a total value of $31,957.90. The disclosure for this sale can be found here. 0.88% of the stock is owned by company insiders.

About Monsanto

Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.

5 Day Chart for NYSE:MON

Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.